Clinical Trials Related to Cartesian Therapeutics

Related studies linked through entity extraction aliases.

Descartes-08 in Autoantibody Myositis

Status: RECRUITING
Phase: PHASE2

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Status: RECRUITING
Phase: PHASE1/PHASE2

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Status: RECRUITING
Phase: PHASE3

Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma

Status: TERMINATED
Phase: PHASE1

Descartes-08 for Patients With Systemic Lupus Erythematosus

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Descartes-25 in Relapsed/Refractory Multiple Myeloma

Status: TERMINATED
Phase: PHASE1

Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy

Status: TERMINATED
Phase: PHASE2

Study of Descartes-30 in Acute Respiratory Distress Syndrome

Status: TERMINATED
Phase: PHASE1

Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy

Status: COMPLETED
Phase: PHASE2

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma

Status: TERMINATED
Phase: PHASE1

Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma

Status: TERMINATED
Phase: PHASE1